Your session is about to expire
← Back to Search
Procedure
Cordotomy for Cancer Pain Management
N/A
Recruiting
Led By Eduardo Bruera
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Unilateral pain due to cancer below the shoulder level (arm, trunk, hip, leg)
Has undergone 3 palliative care evaluations
Must not have
Uncorrectable coagulopathy
Large intracranial mass
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
Approved for 5 Other Conditions
All Individual Drugs Already Approved
Summary
This trial studies how well cordotomy works in reducing severe pain in patients with advanced cancer. Cordotomy involves using a needle to make a small cut in the spinal cord, which helps block pain signals from reaching the brain. The goal is to see if this method can effectively reduce pain when other treatments don't work. Cordotomy has been used since 1912 and has evolved from a more invasive open surgical procedure to a less invasive percutaneous radiofrequency procedure.
Who is the study for?
This trial is for advanced cancer patients with pain intensity of 4 or higher on a scale of 0-10, specifically below the shoulder level. Participants must have had three palliative care evaluations and be able to consent. Those who can't complete forms, have less than a month to live, issues with blood clotting, sedation risks, brain tumors or morphine allergies cannot join.
What is being tested?
The study tests if cordotomy—a needle procedure on the spinal cord guided by CT scans—can reduce severe cancer-related pain better than standard treatments like morphine. Patients will also answer questionnaires about their pain levels.
What are the potential side effects?
Cordotomy may cause discomfort at the injection site, potential nerve damage leading to weakness or numbness, and risks associated with sedation. Morphine's side effects include drowsiness, constipation, nausea and potential dependency.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have cancer-related pain in one side of my body below the shoulder.
Select...
I have had three evaluations for symptom management and support.
Select...
My pain level is 4 or higher on a scale of 0 to 10.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a blood clotting disorder that cannot be corrected.
Select...
I have a large brain tumor.
Select...
I cannot have medicines that make me sleep through an IV.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Reduction in pain intensity
Secondary study objectives
Brief Pain Inventory pain interference items
Other ESAS symptoms
Awards & Highlights
Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Group I (cordotomy)Experimental Treatment2 Interventions
Patients undergo a cordotomy over 1-2 hours.
Group II: Group II (morphine, fake cordotomy)Placebo Group3 Interventions
Patients receive morphine via injection into the spine and undergo a fake cordotomy over 1-2 hours.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cordotomy
2015
N/A
~20
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Cordotomy is a surgical procedure that interrupts pain pathways in the spinal cord, providing relief for cancer patients with severe, refractory pain. This is particularly important for those with advanced cancer, as it can significantly improve their quality of life.
Other treatments, such as radiation therapy, work by shrinking tumors that cause pain through pressure on nerves or bones. Pharmacologic approaches, including opioids and adjuvant analgesics, modulate pain perception at different points in the nervous system.
Understanding these mechanisms allows for personalized pain management strategies, enhancing patient comfort and daily functioning.
Surgical cordotomy helps psychosocial suffering.Minimally Invasive Cordotomy for Refractory Cancer Pain: A Randomized Controlled Trial.
Surgical cordotomy helps psychosocial suffering.Minimally Invasive Cordotomy for Refractory Cancer Pain: A Randomized Controlled Trial.
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,917 Previous Clinical Trials
41,014,426 Total Patients Enrolled
M.D. Anderson Cancer CenterLead Sponsor
3,065 Previous Clinical Trials
1,802,182 Total Patients Enrolled
National Institute of Nursing Research (NINR)NIH
600 Previous Clinical Trials
10,377,731 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have cancer-related pain in one side of my body below the shoulder.I have a blood clotting disorder that cannot be corrected.I have a large brain tumor.I cannot have medicines that make me sleep through an IV.I have had three evaluations for symptom management and support.Your doctor thinks you may not survive for more than a month.My pain level is 4 or higher on a scale of 0 to 10.You are allergic to morphine.
Research Study Groups:
This trial has the following groups:- Group 1: Group II (morphine, fake cordotomy)
- Group 2: Group I (cordotomy)
Awards:
This trial has 2 awards, including:- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger